Elevated numbers and altered subsets of procoagulant microparticles in breast cancer patients using endocrine therapy

Thrombosis Research

Volumn 127, Issue 4, 2011, Pages 363-369

  Trappenburg, Marijke C ^a   Van Schilfgaarde, Muriel ^a   Bredewold, Edwin O ^a   Van Aalderen, Michiel C ^a   Spronk, Henri M H ^b   Ten Cate, Hugo ^b   Leyte, Anja ^a   Terpstra, Wim E ^a  

^a Onze Lieve Vrouwe Gasthuis ^*  (Netherlands)

^b MAASTRICHT UNIVERSITY   (Netherlands)

Author keywords

Breast cancer; Endocrine therapy; Microparticles; P selectin; Thrombin generation; Tissue factor

Indexed keywords

ANASTROZOLE; AROMATASE INHIBITOR; CD45 ANTIGEN; EXEMESTANE; FIBRINOGEN RECEPTOR; FULVESTRANT; LEZETROLE; LIPOCORTIN 5; PADGEM PROTEIN; PROCOAGULANT; TAMOXIFEN; THROMBOPLASTIN; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER HORMONE THERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE COURSE; FEMALE; FLOW CYTOMETRY; HUMAN; MEMBRANE MICROPARTICLE; PLASMA; PRIORITY JOURNAL; RISK FACTOR; THROMBIN TIME; THROMBOCYTE; THROMBOSIS;

ADULT; AGED; ANTINEOPLASTIC AGENTS; BREAST; BREAST NEOPLASMS; CELL-DERIVED MICROPARTICLES; FEMALE; HUMANS; MIDDLE AGED; THROMBIN; THROMBOSIS;

EID: 79952991961     PISSN: 00493848     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.thromres.2010.12.015     Document Type: Article

References (33)

1. A. Tedgui, and Z. Mallat Apoptosis as a determinant of atherothrombosis Thromb Haemost 86 1 2001 Jul 420 426 (Pubitemid 32663971)
2. P. Davizon, and J.A. Lopez Microparticles and thrombotic disease Curr Opin Hematol 16 5 2009 Sep 334 341
3. F.R. Rickles, M. Levine, and R.L. Edwards Hemostatic alterations in cancer patients Cancer Metastasis Rev 11 3-4 1992 Nov 237 248
4. A.K. Kakkar, N. DeRuvo, V. Chinswangwatanakul, S. Tebbutt, and R.C. Williamson Extrinsic-pathway activation in cancer with high factor VIIa and tissue factor Lancet 346 8981 1995 Oct 14 1004 1005
5. A. Varki Trousseau's syndrome: multiple definitions and multiple mechanisms Blood 110 6 2007 Sep 15 1723 1729 (Pubitemid 47443881)
6. M. Wahrenbrock, L. Borsig, D. Le, N. Varki, and A. Varki Selectin-mucin interactions as a probable molecular explanation for the association of Trousseau syndrome with mucinous adenocarcinomas J Clin Invest 112 6 2003 Sep 853 862 (Pubitemid 38063743)
7. M.C. Trappenburg, M. van Schilfgaarde, M. Marchetti, H.M. Spronk, H. ten Cate, and A. Leyte Elevated procoagulant microparticles expressing endothelial and platelet markers in essential thrombocythemia Haematologica 94 7 2009 Jul 911 918
8. M.E. Tesselaar, F.P. Romijn, D.L.I. Van, F.A. Prins, R.M. Bertina, and S. Osanto Microparticle-associated tissue factor activity: a link between cancer and thrombosis? J Thromb Haemost 5 3 2007 Mar 520 527 (Pubitemid 46680685)
9. G. Hron, M. Kollars, H. Weber, V. Sagaster, P. Quehenberger, and S. Eichinger Tissue factor-positive microparticles: cellular origin and association with coagulation activation in patients with colorectal cancer Thromb Haemost 97 1 2007 Jan 119 123 (Pubitemid 46242392)
10. H.K. Kim, K.S. Song, Y.S. Park, Y.H. Kang, Y.J. Lee, and K.R. Lee Elevated levels of circulating platelet microparticles, VEGF, IL-6 and RANTES in patients with gastric cancer: possible role of a metastasis predictor Eur J Cancer 39 2 2003 Jan 184 191 (Pubitemid 36057068)
11. B. Toth, S. Liebhardt, K. Steinig, N. Ditsch, A. Rank, and I. Bauerfeind Platelet-derived microparticles and coagulation activation in breast cancer patients Thromb Haemost 100 4 2008 Oct 663 669
12. U. Rauch, D. Bonderman, B. Bohrmann, J.J. Badimon, J. Himber, and M.A. Riederer Transfer of tissue factor from leukocytes to platelets is mediated by CD15 and tissue factor Blood 96 1 2000 Jul 1 170 175 (Pubitemid 30456467)
13. J. Cuzick, T. Powles, U. Veronesi, J. Forbes, R. Edwards, and S. Ashley Overview of the main outcomes in breast-cancer prevention trials Lancet 361 9354 2003 Jan 25 296 300 (Pubitemid 36126189)
14. K.D. Pemberton, E. Melissari, and V.V. Kakkar The influence of tamoxifen in vivo on the main natural anticoagulants and fibrinolysis Blood Coagul Fibrinolysis 4 6 1993 Dec 935 942 (Pubitemid 24028823)
15. M. Cushman, J.P. Costantino, E.G. Bovill, D.L. Wickerham, L. Buckley, and J.D. Roberts Effect of tamoxifen on venous thrombosis risk factors in women without cancer: the Breast Cancer Prevention Trial Br J Haematol 120 1 2003 Jan 109 116 (Pubitemid 36056917)
16. M. Erman, H. Abali, B. Oran, I.C. Haznedaroglu, H. Canpinar, and S. Kirazli Tamoxifen-induced tissue factor pathway inhibitor reduction: a clue for an acquired thrombophilic state? Ann Oncol 15 11 2004 Nov 1622 1626 (Pubitemid 39562601)
17. M.N. Levine Adjuvant therapy and thrombosis: how to avoid the problem? Breast 16 Suppl 2 2007 Dec S169 S174
18. R.C. Coombes, E. Hall, L.J. Gibson, R. Paridaens, J. Jassem, and T. Delozier A randomized trial of exemestane after two to three years of tamoxifen therapy in postmenopausal women with primary breast cancer N Engl J Med 350 11 2004 Mar 11 1081 1092 (Pubitemid 38298988)
19. Y. Dobrydneva, R.V. Weatherman, J.P. Trebley, M.M. Morrell, M.C. Fitzgerald, and C.E. Fichandler Tamoxifen stimulates calcium entry into human platelets J Cardiovasc Pharmacol 50 4 2007 Oct 380 390 (Pubitemid 350303815)
20. O. Vitseva, D.A. Flockhart, Y. Jin, S. Varghese, and J.E. Freedman The effects of tamoxifen and its metabolites on platelet function and release of reactive oxygen intermediates J Pharmacol Exp Ther 312 3 2005 Mar 1144 1150 (Pubitemid 40293775)
21. A. Mezentsev, R.M. Merks, E. O'Riordan, J. Chen, N. Mendelev, and M.S. Goligorsky Endothelial microparticles affect angiogenesis in vitro: role of oxidative stress Am J Physiol Heart Circ Physiol 289 3 2005 Sep H1106 H1114
22. H.K. Kim, K.S. Song, J.H. Chung, K.R. Lee, and S.N. Lee Platelet microparticles induce angiogenesis in vitro Br J Haematol 124 3 2004 Feb 376 384 (Pubitemid 38167990)
23. A. Howell, J. Cuzick, M. Baum, A. Buzdar, M. Dowsett, and J.F. Forbes Results of the ATAC (Arimidex, Tamoxifen, Alone or in Combination) trial after completion of 5 years' adjuvant treatment for breast cancer Lancet 365 9453 2005 Jan 1 60 62
24. D.W. Sommeijer, K. Joop, A. Leyte, P.H. Reitsma, and H. ten Cate Pravastatin reduces fibrinogen receptor gpIIIa on platelet-derived microparticles in patients with type 2 diabetes J Thromb Haemost 3 6 2005 Jun 1168 1171 (Pubitemid 41725237)
25. W. Jy, L.L. Horstman, J.J. Jimenez, Y.S. Ahn, E. Biro, and R. Nieuwland Measuring circulating cell-derived microparticles J Thromb Haemost 2 10 2004 Oct 1842 1851 (Pubitemid 40197488)
26. R. Nieuwland, R.J. Berckmans, S. McGregor, A.N. Boing, F.P. Romijn, and R.G. Westendorp Cellular origin and procoagulant properties of microparticles in meningococcal sepsis Blood 95 3 2000 Feb 1 930 935 (Pubitemid 30063043)
27. A.W. Dielis, E. Castoldi, H.M. Spronk, R. van Oerle, K. Hamulyak, and H. ten Cate Coagulation factors and the protein C system as determinants of thrombin generation in a normal population J Thromb Haemost 6 1 2008 Jan 125 131
28. H.M. Spronk, A.W. Dielis, E. de Smedt, R. van Oerle, D. Fens, and M.H. Prins Assessment of thrombin generation II: Validation of the Calibrated Automated Thrombogram in platelet-poor plasma in a clinical laboratory Thromb Haemost 100 2 2008 Aug 362 364
29. A. Borchiellini, K. Fijnvandraat, J.W. ten Cate, D. Pajkrt, S.J. van Deventer, and G. Pasterkamp Quantitative analysis of von Willebrand factor propeptide release in vivo: effect of experimental endotoxemia and administration of 1-deamino-8-D-arginine vasopressin in humans Blood 88 8 1996 Oct 15 2951 2958 (Pubitemid 26357375)
30. J.A. van Mourik, R. Boertjes, I.A. Huisveld, K. Fijnvandraat, D. Pajkrt, and P.J. van Genderen von Willebrand factor propeptide in vascular disorders: A tool to distinguish between acute and chronic endothelial cell perturbation Blood 94 1 1999 Jul 1 179 185 (Pubitemid 29300147)
31. B. Toth, R. Nieuwland, S. Liebhardt, N. Ditsch, K. Steinig, and P. Stieber Circulating microparticles in breast cancer patients: a comparative analysis with established biomarkers Anticancer Res 28 2A 2008 Mar 1107 1112 (Pubitemid 351578961)
32. S. Falati, Q. Liu, P. Gross, G. Merrill-Skoloff, J. Chou, and E. Vandendries Accumulation of tissue factor into developing thrombi in vivo is dependent upon microparticle P-selectin glycoprotein ligand 1 and platelet P-selectin J Exp Med 197 11 2003 Jun 2 1585 1598 (Pubitemid 36682554)
33. I. Hrachovinova, B. Cambien, A. Hafezi-Moghadam, J. Kappelmayer, R.T. Camphausen, and A. Widom Interaction of P-selectin and PSGL-1 generates microparticles that correct hemostasis in a mouse model of hemophilia A Nat Med 9 8 2003 Aug 1020 1025 (Pubitemid 37021781)